{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Group+Regimen&page=27", "query": { "intervention": "Control Group Regimen", "page": 27 }, "page_size": 10 }, "pagination": { "page": 27, "page_size": 10, "total_count": 969, "total_pages": 97, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Group+Regimen&page=28&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Group+Regimen&page=26&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-25T12:18:06.317Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01346969", "title": "Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Reduction in Hypertrophic Skin Scarring" ], "interventions": [ { "name": "EXC 001", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 68, "start_date": "2011-06-01", "completion_date": "2012-04-16", "has_results": true, "last_update_posted_date": "2021-09-09", "last_synced_at": "2026-10-25T12:18:06.317Z", "location_count": 12, "location_summary": "Pasadena, California • Whittier, California • Lake Worth, Florida + 7 more", "locations": [ { "city": "Pasadena", "state": "California" }, { "city": "Whittier", "state": "California" }, { "city": "Lake Worth", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01346969" }, { "nct_id": "NCT03997331", "title": "Chronicare for Type 2 Diabetes (Chronicare-T2D)", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "CRx Health", "type": "OTHER" }, { "name": "Chronicare", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "QuiO", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 100, "start_date": "2020-05", "completion_date": "2021-02", "has_results": false, "last_update_posted_date": "2020-03-31", "last_synced_at": "2026-10-25T12:18:06.317Z", "location_count": 1, "location_summary": "Midland, Michigan", "locations": [ { "city": "Midland", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT03997331" }, { "nct_id": "NCT04741750", "title": "Increasing HCV Linkage to Care Among People Who Inject Drugs", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hepatitis C" ], "interventions": [ { "name": "Simplified HCV care within a mobile medical unit", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Family Health Centers of San Diego", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2021-02-02", "completion_date": "2023-09-30", "has_results": false, "last_update_posted_date": "2024-02-07", "last_synced_at": "2026-10-25T12:18:06.317Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04741750" }, { "nct_id": "NCT04829682", "title": "Testing the Efficacy of ACT for Life", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Suicide" ], "interventions": [ { "name": "ACT for Life", "type": "BEHAVIORAL" }, { "name": "Present Centered Therapy", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "89 Years", "sex": "ALL", "summary": "18 Years to 89 Years" }, "enrollment_count": 278, "start_date": "2022-10-01", "completion_date": "2027-03-31", "has_results": false, "last_update_posted_date": "2026-04-14", "last_synced_at": "2026-10-25T12:18:06.317Z", "location_count": 2, "location_summary": "Aurora, Colorado • Battle Creek, Michigan", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Battle Creek", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT04829682" }, { "nct_id": "NCT03301597", "title": "NLA101 in Adults Receiving High Dose Chemotherapy for AML", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Leukemia, Myeloid, Acute" ], "interventions": [ { "name": "NLA101", "type": "BIOLOGICAL" }, { "name": "Standard of Care (SOC) chemotherapy", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Nohla Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 146, "start_date": "2018-01-24", "completion_date": "2019-03-18", "has_results": false, "last_update_posted_date": "2021-03-30", "last_synced_at": "2026-10-25T12:18:06.317Z", "location_count": 25, "location_summary": "La Jolla, California • Los Angeles, California • Sacramento, California + 19 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03301597" }, { "nct_id": "NCT02163226", "title": "A Randomized Trial Evaluating Rapid Delivery of Dose Escalated Hypofractionated Radiotherapy for Patients Diagnosed With Bone Metastases for Effective Palliation of Symptoms", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Bone Metastases" ], "interventions": [ { "name": "Hypofractionated Radiation Treatment", "type": "RADIATION" }, { "name": "One Radiation Treatment", "type": "RADIATION" }, { "name": "Questionnaire", "type": "BEHAVIORAL" } ], "intervention_types": [ "RADIATION", "BEHAVIORAL" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 167, "start_date": "2014-08-06", "completion_date": "2020-09-02", "has_results": true, "last_update_posted_date": "2021-11-08", "last_synced_at": "2026-10-25T12:18:06.317Z", "location_count": 3, "location_summary": "Gilbert, Arizona • Voorhees Township, New Jersey • Houston, Texas", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Voorhees Township", "state": "New Jersey" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02163226" }, { "nct_id": "NCT03193190", "title": "A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Pancreatic Adenocarcinoma" ], "interventions": [ { "name": "Nab-Paclitaxel", "type": "DRUG" }, { "name": "Gemcitabine", "type": "DRUG" }, { "name": "Oxaliplatin", "type": "DRUG" }, { "name": "Leucovorin", "type": "DRUG" }, { "name": "Fluorouracil", "type": "DRUG" }, { "name": "Atezolizumab", "type": "DRUG" }, { "name": "Cobimetinib", "type": "DRUG" }, { "name": "PEGPH20", "type": "DRUG" }, { "name": "BL-8040", "type": "DRUG" }, { "name": "Selicrelumab", "type": "DRUG" }, { "name": "Bevacizumab", "type": "DRUG" }, { "name": "RO6874281", "type": "DRUG" }, { "name": "AB928", "type": "DRUG" }, { "name": "Tiragolumab", "type": "DRUG" }, { "name": "Tocilizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 341, "start_date": "2017-07-05", "completion_date": "2025-02-27", "has_results": true, "last_update_posted_date": "2025-11-21", "last_synced_at": "2026-10-25T12:18:06.317Z", "location_count": 12, "location_summary": "Duarte, California • San Francisco, California • New Haven, Connecticut + 8 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03193190" }, { "nct_id": "NCT03677778", "title": "Interscalene Brachial Plexus Block Washout to Reverse Inadvertent Phrenic Nerve Blockade", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Anesthesia, Local", "Phrenic Nerve Paralysis", "Upper Extremity Injury", "Phrenic Nerve Palsy on the Left", "Phrenic Nerve Palsy on the Right" ], "interventions": [ { "name": "Normal saline injected via interscalene nerve catheter", "type": "PROCEDURE" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 43, "start_date": "2018-10-22", "completion_date": "2022-07-07", "has_results": false, "last_update_posted_date": "2022-08-02", "last_synced_at": "2026-10-25T12:18:06.317Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03677778" }, { "nct_id": "NCT04522206", "title": "An Analysis of the Efficacy of a Pre-Emptive Multimodal Pain Regimen in Reducing Acute Post-Operative Pain and Narcotic Pain Medication Requirements in Spine Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pain, Postoperative", "Spine Injuries and Disorders", "Narcotic Use" ], "interventions": [ { "name": "Pre-op Multimodal analgesia (MMA) regimen + standard post-op oxycodone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 44, "start_date": "2020-08-20", "completion_date": "2021-06-10", "has_results": true, "last_update_posted_date": "2022-07-11", "last_synced_at": "2026-10-25T12:18:06.317Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04522206" }, { "nct_id": "NCT05776563", "title": "Reversibility of Brain Glucose Transport in Type 2 Diabetes Mellitus (T2DM)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "Nutrition visits", "type": "BEHAVIORAL" }, { "name": "Intensification of diabetes regimen", "type": "OTHER" }, { "name": "Continuous glucose monitor (CGM)", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 24, "start_date": "2024-07-19", "completion_date": "2027-05-31", "has_results": false, "last_update_posted_date": "2026-10-09", "last_synced_at": "2026-10-25T12:18:06.317Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT05776563" } ] }